Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-29
DOI
10.1038/s41589-022-01015-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
- (2021) Edward L. Huttlin et al. CELL
- Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
- (2020) Sida Shen et al. ACS Medicinal Chemistry Letters
- A lipidome atlas in MS-DIAL 4
- (2020) Hiroshi Tsugawa et al. NATURE BIOTECHNOLOGY
- The MiDAC histone deacetylase complex is essential for embryonic development and has a unique multivalent structure
- (2020) Robert E. Turnbull et al. Nature Communications
- Metallo-β-Lactamase Domain-Containing Protein 2 (MBLAC2) is S-palmitoylated and exhibits acyl-CoA hydrolase activity
- (2020) Martin Ian P. Malgapo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors
- (2019) Maria Reinecke et al. ACS Chemical Biology
- Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
- (2019) Magalie Géraldy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hdac4 interactions in Huntington’s Disease viewed through the prism of multiomics
- (2019) Joel D Federspiel et al. MOLECULAR & CELLULAR PROTEOMICS
- Recent advances in class IIa histone deacetylases research
- (2019) Yodita Asfaha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- ilastik: interactive machine learning for (bio)image analysis
- (2019) Stuart Berg et al. NATURE METHODS
- Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
- (2019) Ann Lin et al. Science Translational Medicine
- Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway
- (2019) Bo Gao et al. CARCINOGENESIS
- Co-regulation map of the human proteome enables identification of protein functions
- (2019) Georg Kustatscher et al. NATURE BIOTECHNOLOGY
- HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease
- (2018) Veronick Benoy et al. BRAIN
- Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance
- (2018) Johannes Ridinger et al. Scientific Reports
- CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies
- (2018) Nathan O. Fuller et al. ACS Chemical Neuroscience
- Acetylation of intrinsically disordered regions regulates phase separation
- (2018) Makoto Saito et al. Nature Chemical Biology
- The HDAC6 Inhibitor Tubacin Induces Release of CD133+ Extracellular Vesicles From Cancer Cells
- (2017) Olivia S. Chao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives
- (2017) Gebremedhin S. Hailu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Class I Histone Deacetylases in a “Complex” Environment
- (2017) Christopher J. Millard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
- (2017) Wenting Guo et al. Nature Communications
- Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
- (2017) Yang Hai et al. Nature Communications
- Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
- (2016) Susan Klaeger et al. ACS Chemical Biology
- Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
- (2016) Tino Heimburg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling
- (2016) Kristin B. Runkle et al. MOLECULAR CELL
- Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
- (2016) Isabelle Becher et al. Nature Chemical Biology
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
- (2016) Veronick Benoy et al. Neurotherapeutics
- Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
- (2016) Peter J. Watson et al. Nature Communications
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Studying epigenetic complexes and their inhibitors with the proteomics toolbox
- (2016) David Weigt et al. Clinical Epigenetics
- Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling
- (2015) Guillaume Médard et al. JOURNAL OF PROTEOME RESEARCH
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors
- (2015) Christopher A. Luckhurst et al. ACS Medicinal Chemistry Letters
- Target engagement and drug residence time can be observed in living cells with BRET
- (2015) Matthew B. Robers et al. Nature Communications
- Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
- (2014) Isabelle Becher et al. ACS Chemical Biology
- Optimizing a ultrahigh pressure liquid chromatography-time of flight-mass spectrometry approach using a novel sub-2μm core–shell particle for in depth lipidomic profiling of Caenorhabditis elegans
- (2014) Michael Witting et al. JOURNAL OF CHROMATOGRAPHY A
- MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors
- (2014) W. A. Gold et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
- (2014) Jürgen Cox et al. MOLECULAR & CELLULAR PROTEOMICS
- Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
- (2013) Roland W. Bürli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Histone deacetylase 10 promotes autophagy-mediated cell survival
- (2013) I. Oehme et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3
- (2011) F. H. Bardai et al. JOURNAL OF NEUROSCIENCE
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro
- (2008) Benjamin C. Jennings et al. JOURNAL OF LIPID RESEARCH
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
- (2008) K. Trajkovic et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started